Infrastructure route under development
The company linked Marillana development to MinRes-Hancock port and transport infrastructure work. Project expenditure included the group’s share of joint-operation costs.
Brockman held a large iron-ore exploration asset base but little cash relative to its obligations. Marillana’s development remained dependent on infrastructure and approvals, while borrowing, payable remeasurement and tax effects strongly influenced the financial results.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Group cash, not an undrawn facility.
After tax and finance effects.
Other payables shown separately.
Carrying value, not production revenue.
Marillana is a 50%-owned development interest. Technical work progressed, but the infrastructure solution to be arranged by MinRes or its subsidiaries had not yet been implemented in the FY2026 report. A resource or reserve base alone therefore does not establish operating cash generation.
The financing structure includes shareholder borrowing and Polaris-related obligations with different repayment terms. Their accrual interest, remeasurement and funding timing must be distinguished from actual cash payments.
The company linked Marillana development to MinRes-Hancock port and transport infrastructure work. Project expenditure included the group’s share of joint-operation costs.
The larger reported loss reflected a much higher share of joint-operation expenditure, partly offset by tax recognition. Infrastructure corridor permissions remained relevant.
On-ground Marillana technical studies were completed; environmental updates and hydrological modelling continued. Punda Springs reconnaissance drilling also progressed.
A non-core tenement sale contributed a gain while project development continued. No project capital expenditure was recognised, which is not the same as no exploration expense.
Plant designs and approvals remained in progress. The shareholder facility was increased in December2025 and extended to December2027. Ophthalmia’s July2026 agreement is subsequent to this year-end.
Operating activities consumed cash in every year shown. Borrowing inflows supported continued activity, but cash stayed low by the end of FY2026. The undrawn shareholder facility disclosed at the report date is not added to year-end cash.
HK$ million
AI-generated presentation · values from Five-year financial record; no missing values plotted as zero.
HK$ million
AI-generated presentation · values from Five-year financial record; no missing values plotted as zero.
HK$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Net loss after tax | (20.814) | (56.556) | (13.362) | (34.612) | (28.783) |
| Operating cash flow | (20.173) | (19.242) | (19.199) | (18.576) | (19.605) |
| Investing cash flow | (0.165) | 0.082 | 1.557 | 2.707 | (0.069) |
| Financing cash flow | 5.150 | 7.605 | 5.843 | 16.769 | 18.355 |
| Closing cash | 28.797 | 16.495 | 4.559 | 5.274 | 3.922 |
Years ended 30 June2022-2026. HK$000 statement values converted to HK$ million, not Australian dollars.
Development remains pre-production; investing receipts can include non-core tenement disposals rather than product sales.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2023’s exceptionally high exploration charge included substantial joint-operation expenditure. More recently, interest costs were partly offset by gains on payable remeasurement, and the tax line changed from expense to benefit. These are not indications of iron-ore sales commencing.
HK$ million
AI-generated presentation · values from Five-year financial record; no missing values plotted as zero.
HK$ million
| Metric | FY2025 | FY2026 |
|---|---|---|
| Exploration and evaluation expense | (6.488) | (9.024) |
| Finance income | 9.758 | 14.564 |
| Finance costs | (16.024) | (21.030) |
| Tax benefit / (expense) | (7.684) | 2.662 |
| Net loss | (34.612) | (28.783) |
Finance income includes payable remeasurement effects; it is not gold or iron-ore sales.
Tax recognition and non-cash finance effects mean profit/loss does not equal cash consumed. Statement finance costs are not replaced with a differently presented cash-reconciliation add-back.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The FY2026 mining-property roll-forward attributes its increase to exchange differences. It would therefore be incorrect to interpret that increase as new capital expenditure, resource tonnage growth or realised project value.
HK$ million
AI-generated presentation · values from Mining properties dominate the group balance sheet; no missing values plotted as zero.
HK$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Total group assets | 765.225 | 724.809 | 713.302 | 704.761 | 740.242 |
| Total group equity | 590.137 | 511.212 | 498.524 | 456.414 | 454.012 |
| Mining exploration properties | 733.677 | 705.842 | 706.596 | 697.691 | 733.524 |
Mining exploration properties are accounting carrying values, not liquid assets or forecast sales.
FY2026 increase in this property balance is explained by exchange translation, not additional cash investment.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The shareholder loan bears17% annual interest and was extended to31December2027. Polaris advances have separate security and repayment terms linked to Brockman’s share of net product revenue. These balances should not be combined into a single assumed cash repayment schedule.
The FY2026 year-end had net current liabilities. A subsequent1July2026 agreement concerning Ophthalmia affected a Polaris payable; that subsequent relief is disclosed, not used to erase the June obligation. The auditor highlighted material going-concern uncertainty without modifying its opinion.
HK$ million
AI-generated presentation · values from Liquidity and shareholder-related funding; no missing values plotted as zero.
HK$ million
| Metric | FY2025 | FY2026 |
|---|---|---|
| Current assets | 6.164 | 4.770 |
| Current liabilities subtotal | 2.080 | 8.906 |
| Non-current borrowings | 92.461 | 126.753 |
| Cash proceeds from borrowings | 17.189 | 18.814 |
| Non-current other payables | 67.643 | 61.750 |
Current liabilities use the actual subtotal, not an empty section heading encoded as nil in the extraction.
Year-end liabilities remain shown before the subsequent Ophthalmia agreement. Borrowings and other payables are different balances.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The exploration expense includes the group’s share of joint-operation costs. The specific exploration cash disclosure is part of operating cash and must not be added to total operating cash as though it were separate.
HK$ million
AI-generated presentation · values from Expense is not the same as cash paid by the group; no missing values plotted as zero.
HK$ million
| Metric | FY2025 | FY2026 |
|---|---|---|
| Exploration and evaluation expense | (6.488) | (9.024) |
| Exploration cash within operating activities | (2.193) | (4.735) |
The expense includes the group’s joint-operation expenditure. Funding arrangements and non-cash/accrual effects prevent treating the expense as cash paid in that year.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.